Please Wait
Applying Filters...
menu
    • menu
    Anhui Ribobay-PSE
    News
    Ribobay Pharma to start production of cGMP-level oligonucleotide

    18 Sep 2024

    // CRTMAGAZINE

    Ribobay Pharma boosts CRDMO offerings with Cytiva

    10 May 2024

    // PR NEWSWIRE

    Jazz Pharma receive FDA approval for biliary tract cancer treatment

    21 Nov 2024

    // REUTERS

    Data Compilation
    #PharmaFlow

    Ribobay VB RM

    Contact Supplier

    Website

    BMWS24

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
    Menu

    Anhui Ribobay Pharmaceutical Co.,Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    Key Services KEY SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Givosiran

    02 1Inclisiran

    03 1Inotersen Sodium

    04 1Nusinersen

    05 1Patisiran

    06 1Viltolarsen

    07 1Volanesorsen Sodium

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Givosiran

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
      Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
      Ribobay-Company-Banner

      01

      Givosiran

      China
      arrow
      Fi Europe 2024
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Anhui Ribobay Pharmaceutical Co.,Ltd

      Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

      About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

      Ribobay-Company-Banner

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
        Contact Supplier Contact Supplier
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Inclisiran

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
        Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
        Ribobay-Company-Banner

        02

        Inclisiran

        China
        arrow
        Fi Europe 2024
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
        Contact Supplier Contact Supplier
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Anhui Ribobay Pharmaceutical Co.,Ltd

        Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

        About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

        Ribobay-Company-Banner

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Inotersen Sodium

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
          Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
          Ribobay-Company-Banner

          03

          Inotersen Sodium

          China
          arrow
          Fi Europe 2024
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Anhui Ribobay Pharmaceutical Co.,Ltd

          Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

          About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

          Ribobay-Company-Banner

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
            Contact Supplier Contact Supplier
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Nusinersen

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
            Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
            Ribobay-Company-Banner

            04

            Nusinersen

            China
            arrow
            Fi Europe 2024
            Not Confirmed
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
            Contact Supplier Contact Supplier
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Anhui Ribobay Pharmaceutical Co.,Ltd

            Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

            About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

            Ribobay-Company-Banner

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
              Contact Supplier Contact Supplier
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Patisiran

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
              Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
              Ribobay-Company-Banner

              05

              Patisiran

              China
              arrow
              Fi Europe 2024
              Not Confirmed
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
              Contact Supplier Contact Supplier
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Anhui Ribobay Pharmaceutical Co.,Ltd

              Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

              About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

              Ribobay-Company-Banner

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
                Contact Supplier Contact Supplier
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Viltolarsen

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
                Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
                Ribobay-Company-Banner

                06

                Viltolarsen

                China
                arrow
                Fi Europe 2024
                Not Confirmed
                • fda
                • EDQM
                • WHO-GMP
                Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
                Contact Supplier Contact Supplier
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Anhui Ribobay Pharmaceutical Co.,Ltd

                Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

                About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

                Ribobay-Company-Banner

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Contact Supplier
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
                  Contact Supplier Contact Supplier
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Volanesorsen Sodium

                  Product
                  Web Link

                  Stock Recap
                  #PipelineProspector

                  Market
                  Place

                  Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol...
                  Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.
                  Ribobay-Company-Banner

                  07

                  Volanesorsen Sodium

                  China
                  arrow
                  Fi Europe 2024
                  Not Confirmed
                  • fda
                  • EDQM
                  • WHO-GMP
                  Virtual BoothRibobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
                  Contact Supplier Contact Supplier
                  Flag China
                  Virtual Booth Virtual Booth
                  Digital Content Digital Content

                  Anhui Ribobay Pharmaceutical Co.,Ltd

                  Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within the Nanjing metropolitan area, Ribobay Pharmaceutical specializes in the therapeutic oligonucleotides CXO field. This strategic focus aligns with General Biol's broader expansion plans for its CXO business, making Ribobay a crucial component of the company's ventures in this domain.

                  About the Company : Anhui Ribobay Pharmaceutical Co., Ltd., known as Ribobay, was established in August 2021 as a fully owned subsidiary of General Biol. Situated in the Quanjiao industry Zone in Chuzhou, within th...

                  Ribobay-Company-Banner

                  Product
                  Web Link

                  Stock Recap
                  #Pipeline Prospector

                  Market
                  Place

                  Contact Anhui Ribobay Pharmaceutical Co.,ltd and get a quotation

                  Anhui Ribobay Pharmaceutical Co.,ltd is a supplier offers 7 products (APIs, Excipients or Intermediates).

                  Find a price of Givosiran bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Inclisiran bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Inotersen Sodium bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Nusinersen Sodium bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Patisiran bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Viltolarsen bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd

                  Find a price of Volanesorsen bulk offered by Anhui Ribobay Pharmaceutical Co.,ltd